Harnessing Engineered Immune Cells and Bacteria as Drug Carriers

Immunotherapeutics and Vaccine Research Initiative (IVRI)

Engineering cytokine therapeutics

Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle - Yong - 2022 - Advanced Materials - Wiley Online Library

Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy

Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy

Frontiers Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications

Adoptive T-Cell Therapies: unlocking the potential of engineered antigen receptors - Drug Discovery World (DDW)

Harnessing nanoparticles to fight drug-resistant infections

Q&A: What if Immune Cells Don't Actually Detect Viruses and Bacteria?

Harnessing Synthetic Biology Principles for Pharmaceutical Development

Harnessing bacteria for tumor therapy: Current advances and challenges - ScienceDirect

Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy

Vaccines, Free Full-Text

A New Cancer Treatment That Is Faster, More Efficient and Less Risky Is Coming: Bacteria Bombs - The New York Times